PURPOSE: To address the functional role of radiation-induced transforming growth factor-beta (TGF-beta) signaling in a normal epithelial background, we selected a spontaneously immortalized lung epithelial cell line derived from the normal lung tissue of a dominant-negative mutant of the TGF-beta RII (DeltaRII) transgenic mouse that conditionally expressed DeltaRII under the control of the metallothionein promoter (MT-1), and assessed this cell line's response to radiation. METHODS AND MATERIALS: A spontaneously immortalized lung epithelial cell culture (SILECC) was established and all analyses were performed within 50 passages. Colony-forming and terminal transferase dUPT nick end labeling (TUNEL) assays were used to assess clonogenic inhibition and apoptosis, respectively. Western-blot analysis was performed to assess the kinetics of p21, bax, and RII proteins. Transforming growth factor-beta-responsive promoter activity was measured using dual-luciferase reporter assay. RESULTS: Exposure to ZnSO(4) inhibited TGF-beta signaling induced either by recombinant TGF-beta1 or ionizing radiation. The SILECC, treated with either ZnSO(4) or neutralizing antibody against TGF-beta, showed a significant increase in radio-resistance compared to untreated cells. Furthermore, the expression of DeltaRII inhibited the radiation-induced up-regulation of the TGF-beta effector gene p21(waf1/cip1). CONCLUSIONS: Our findings imply that inhibition of radiation-induced TGF-beta signaling via abrogation of the RII function enhances the radio-resistance of normal lung epithelial cells, and this can be directly attributed to the loss of TGF-beta signaling function.
PURPOSE: To address the functional role of radiation-induced transforming growth factor-beta (TGF-beta) signaling in a normal epithelial background, we selected a spontaneously immortalized lung epithelial cell line derived from the normal lung tissue of a dominant-negative mutant of the TGF-beta RII (DeltaRII) transgenic mouse that conditionally expressed DeltaRII under the control of the metallothionein promoter (MT-1), and assessed this cell line's response to radiation. METHODS AND MATERIALS: A spontaneously immortalized lung epithelial cell culture (SILECC) was established and all analyses were performed within 50 passages. Colony-forming and terminal transferase dUPT nick end labeling (TUNEL) assays were used to assess clonogenic inhibition and apoptosis, respectively. Western-blot analysis was performed to assess the kinetics of p21, bax, and RII proteins. Transforming growth factor-beta-responsive promoter activity was measured using dual-luciferase reporter assay. RESULTS: Exposure to ZnSO(4) inhibited TGF-beta signaling induced either by recombinant TGF-beta1 or ionizing radiation. The SILECC, treated with either ZnSO(4) or neutralizing antibody against TGF-beta, showed a significant increase in radio-resistance compared to untreated cells. Furthermore, the expression of DeltaRII inhibited the radiation-induced up-regulation of the TGF-beta effector gene p21(waf1/cip1). CONCLUSIONS: Our findings imply that inhibition of radiation-induced TGF-beta signaling via abrogation of the RII function enhances the radio-resistance of normal lung epithelial cells, and this can be directly attributed to the loss of TGF-beta signaling function.
Authors: Mansoor M Ahmed; Rachael A Alcock; Damodaran Chendil; Swatee Dey; Anindita Das; Kolaparthi Venkatasubbarao; Mohammed Mohiuddin; LuZhe Sun; William E Strodel; James W Freeman Journal: J Biol Chem Date: 2001-11-01 Impact factor: 5.157
Authors: Y Shima; K Nakao; T Nakashima; A Kawakami; K Nakata; K Hamasaki; Y Kato; K Eguchi; N Ishii Journal: Hepatology Date: 1999-11 Impact factor: 17.425
Authors: Kenneth B Ewan; Rhonda L Henshall-Powell; Shraddha A Ravani; Maria Jose Pajares; Carlos Arteaga; Ray Warters; Rosemary J Akhurst; Mary Helen Barcellos-Hoff Journal: Cancer Res Date: 2002-10-15 Impact factor: 12.701
Authors: K D Fralix; M M Ahmed; C Mattingly; C Swiderski; P C McGrath; K Venkatasubbarao; N Kamada; M Mohiuddin; W E Strodel; J W Freeman Journal: Cancer Date: 2000-05-01 Impact factor: 6.860
Authors: Young Sun; Binh N Tran; Lori A Worley; Rachel B Delston; J William Harbour Journal: Invest Ophthalmol Vis Sci Date: 2005-05 Impact factor: 4.799
Authors: K Venkatasubbarao; M M Ahmed; M Mohiuddin; C Swiderski; E Lee; W R Gower; K F Salhab; P McGrath; W Strodel; J W Freeman Journal: Anticancer Res Date: 2000 Jan-Feb Impact factor: 2.480
Authors: Sigrid A Rajasekaran; Thu P Huynh; Daniel G Wolle; Cromwell E Espineda; Landon J Inge; Anna Skay; Charles Lassman; Susanne B Nicholas; Jeffrey F Harper; Anna E Reeves; Mansoor M Ahmed; James M Leatherman; James M Mullin; Ayyappan K Rajasekaran Journal: Mol Cancer Ther Date: 2010-05-25 Impact factor: 6.261